Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Work In Process: 2014-2024

Historic Work In Process for Ocular Therapeutix (OCUL) over the last 11 years, with Dec 2024 value amounting to $1.5 million.

  • Ocular Therapeutix's Work In Process fell 2.93% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 2.93%. This contributed to the annual value of $1.5 million for FY2024, which is 47.13% up from last year.
  • As of FY2024, Ocular Therapeutix's Work In Process stood at $1.5 million, which was up 47.13% from $1.0 million recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's Work In Process registered a high of $1.5 million during FY2024, and its lowest value of $232,000 during FY2020.
  • In the last 3 years, Ocular Therapeutix's Work In Process had a median value of $1.0 million in 2023 and averaged $1.1 million.
  • Data for Ocular Therapeutix's Work In Process shows a peak YoY spiked of 160.78% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Ocular Therapeutix's Work In Process stood at $232,000 in 2020, then spiked by 160.78% to $605,000 in 2021, then skyrocketed by 48.60% to $899,000 in 2022, then climbed by 12.57% to $1.0 million in 2023, then surged by 47.13% to $1.5 million in 2024.